Citations

Showing 10 of 108094 citations.

Gene‐Specific Variant Classifier (DPYD‐Varifier) to Identify Deleterious Alleles of Dihydropyrimidine Dehydrogenase
Zhang, Cheng , Jerde, Calvin R. , Nie, Qian , Offer, Steven M. , Diasio, Robert B. , Shrestha, Shikshya , Zhang, Cheng , Li, Hu , Offer, Steven M

Mayo Clinic

Clinical Pharmacology & Therapeutics | January 12, 2018 | Volume: 104 | Issue: 4 | Pages: 709-718

10.1002/cpt.1020 | PMID 29327356 Get It

Deleterious variants in dihydropyrimidine dehydrogenase (DPD, DPYD gene) can be highly predictive of clinical toxicity to the widely prescribed chemotherapeutic 5‐fluorouracil (5‐FU). However, there are very limited data pertaining to the functional consequences of the >450 reported no‐synonymous DPYD variants. We developed a DPYD‐specific variant classifier (DPYD‐Varifier) using machine learning and in vitro functional data for 156 missense DPYD variants. The developed model showed 85% accuracy and outperformed other in silico prediction tools. An examination of feature importance within the model provided additional insight into functional aspects of the DPD protein relevant to 5‐FU toxicity. In the absence of clinical data for unstudied variants, prediction tools like DPYD‐Varifier have great potential to individualize medicine and improve the clinical decision‐making process.
A retrospective survey of exposure history to chemotherapy or radiotherapy in 940 consecutive patients with primary myelofibrosis
Nicolosi, Maura , Mudireddy, Mythri , Patnaik, Mrinal M. , Gangat, Naseema , Pardanani, Animesh , Tefferi, Ayalew

Mayo Clinic

American Journal of Hematology | January 12, 2018 | Volume: 93 | Issue: 4 | Pages: No page available

10.1002/ajh.25037 | PMID 29327469 Get It

Mechanical, Cellular, and Proteomic Properties of Laryngotracheal Cartilage
Pauken, Christine, Heyes, Richard , Pauken, Christine M, Lott, David G.

Mayo Clinic

CARTILAGE | January 12, 2018 | Volume: 10 | Issue: 3 | Pages: 321-328

10.1177/1947603517749921 | PMID 29322878 Get It

Great Debates in Vascular Medicine: Should all inferior vena cava (IVC) filters be removed?
Weinberg, Ido , Bjarnason, Haraldur , Bjarnason, Haraldur

Mayo Clinic

Vascular Medicine | January 12, 2018 | Volume: 23 | Issue: 1 | Pages: 75-77

10.1177/1358863x17746247 | PMID 29320958 Get It

Bioelectric Effect and Bacterial Biofilms. a Systematic Review
Pozo, José Luís del , Rouse, Mark S., Patel, Robin , Patel, Robin

Mayo Clinic

The International Journal of Artificial Organs | January 12, 2018 | Volume: 31 | Issue: 9 | Pages: 786-795

10.1177/039139880803100906 | PMID 18924090 Get It

Bacteria growing in biofilms cause a wide range of human infections. Biofilm bacteria are resistant to antimicrobics at levels 500 to 5,000 times higher than those needed to kill non-biofilm bacteria. In vitro experiments have shown that electric current can enhance the activity of some antimicrobial agents against certain bacteria in biofilms; this has been termed the “bioelectric effect”. Direct electrical current has already been safely used in humans for fracture healing. Application of direct electric current with antimicrobial chemotherapy in humans could theoretically abrogate the need to remove the device in device-related infections, a procedure associated with substantial morbidity and cost. In this article, we review what has been described in the literature with regards to the bioelectric effect. (Int J Artif Organs 2008; 31: 786–95)
Prevention of Cardiac Surgery-Associated Acute Kidney Injury
Schetz, Miet , Bove, Tiziana , Morelli, Andrea , Mankad, Sunil , Kellum, John A. , Kellum, John A , Ronco, Claudio

Mayo Clinic

The International Journal of Artificial Organs | January 12, 2018 | Volume: 31 | Issue: 2 | Pages: 179-189

10.1177/039139880803100211 | PMID 18311734 Get It

Numerous strategies have been evaluated to prevent early CSA-AKI. Although correction of hemodynamic problems is paramount, there are no clinical studies that compare different hemodynamic management or monitoring strategies with regard to their effect on kidney function. Pharmacologic strategies including diuretics, different classes of vasodilators and drugs with anti-inflammatory effects such as N-acetyl-cysteine, do not appear to be effective. Most of the studies are underpowered and use physiological rather than clinical endpoints. Further trials are warranted with fenoldopam and nesiritide (rhBNP). Observational and underpowered randomized studies show beneficial renal effects of off-pump technique and avoidance of aortic manipulation. There is very limited evidence for preoperative fluid loading and preemptive RRT. Potentially nephrotoxic agents should be used with caution in patients at risk of CSA-AKI. Tranexamic acid or aminocaproic acid should be preferred over aprotinin. No pharmacologic intervention has been adequately tested in the prevention of late CSA-AKI. A single-center study, including a predominance of patients after cardiac surgery, showed a decrease of kidney injury with tight glycemic control.
Anatomic Total Shoulder Arthroplasty Using a Self-Pressurizing Pegged Bone-Preserving Cemented Glenoid Component: A 2- to 5-Year Follow-up Study
Nguyen, Ngoc Tram V. , Sánchez‐Sotelo, Joaquín , Morrey, Mark E.

Mayo Clinic

Journal of Shoulder and Elbow Arthroplasty | January 12, 2018 | Volume: 2 | Issue: No issue available | Pages: No page available

10.1177/2471549217750478 Get It

Background: High rates of radiographic loosening have been reported with various glenoid designs. Many available designs sacrifice most of the bone at the central portion of the glenoid vault, creating large areas of deficiency when revision becomes necessary. The purpose of this study was to report the 2- to 5-year outcome of shoulder arthroplasty using a bone-preserving all-polyethylene glenoid components with self-pressurizing pegs. Methods: Between August 2011 and December 2014, 202 consecutive anatomic total shoulder arthroplasties (TSAs) were performed by a single surgeon with implantation of a self-pressurizing cemented pegged glenoid component in 190 patients (12 patients had both shoulders replaced). Patients were followed up prospectively and evaluated for pain, motion, strength, American Shoulder and Elbow Surgeons (ASES) scores, and radiographic changes. The mean follow-up time was 2.7 (2–5) years. Results: TSA improved pain and function reliably. At the most recent follow-up, 94% of the shoulders had no or mild pain. Motion included 154 ± 25° of elevation, 68 ± 18° of external rotation, and median internal rotation to T10 (range, iliac crest to T4). The most recent average ASES score was 82 ± 15 points. Early postoperative radiographs showed no radiolucent lines. No humeral or glenoid component was considered radiographically loose at the most recent follow-up. Complications requiring reoperation included subscapularis insufficiency (4), posterior instability (2), deep infection (1), stiffness (1), and a painful loose body (1). No components were revised for loosening. Conclusions: Anatomic TSA using a cemented bone-preserving all-polyethylene pegged self-pressurizing glenoid component provided satisfactory clinical outcomes and survival at 2 to 5 years.
Cost-Effectiveness of Evaluation of Children With Epilepsy in the Emergency Department: Need for Investment in Patient Education
Carvalho, Karen S., Fine, Anthony L. , Haines, Christopher J., Valencia, Ignacio , Khurana, Divya S. , Legido, Agustín, Fine, Anthony

Mayo Clinic

Journal of Child Neurology | January 12, 2018 | Volume: 33 | Issue: 3 | Pages: 193-197

10.1177/0883073817749378 | PMID 29318927 Get It

We aimed to study cost-effectiveness of seizure evaluation of children with epilepsy in the emergency department (ED). We reviewed epilepsy patients seen at our ED for 1 year. Age, laboratory and neuroimaging results, treatment, disposition, and usefulness of the visit (need for hospitalization, clinical improvement) were analyzed. We identified 330 patients, aged 23 days–21 years, 190 (57.5%) had blood tests, 45 (13.6%) urinalysis, 2 (0.6%) cerebrospinal fluid testing, and 44 neuroimaging studies (13.3%). Tests’ positive yield were 41%, 11%, 0%, and 4.5%, respectively. One-third of patients (n = 122) were treated with antiepileptic drugs. Other treatments were administered to 44 (13.3%). One hundred eighteen patients (35.7%) were admitted to our hospital, 208 (63%) discharged to home. Two hundred eight visits were useful (63%). One-third of visits did not provide useful patient care. Their visits were expensive and not very cost-effective. Investment in patient education could decrease unnecessary ED visits.
Sellar Region Atypical Teratoid/Rhabdoid Tumors (ATRT) in Adults Display DNA Methylation Profiles of the ATRT-MYC Subgroup
Johann, Pascal D. , Bens, Susanne , Oyen, Florian, Wagener, Rabea , Raisanen, Jack, Reis, Gerald F. , Nobusawa, Sumihito , Arita, Kazunori , Felsberg, Jörg , Reifenberger, Guido , Buslei, Rolf , Capper, David , Pfister, Stefan M. , Schneppenheim, Reinhard , Siebert, Reiner , Paulus, Werner , Kool, Marcel , Pfister, Stefan M , Giannini, Caterina , Perry, Arie , Agaimy, Abbas , Frühwald, Michael Christoph , Hasselblatt, Martin , Capper, David

Mayo Clinic

American Journal of Surgical Pathology | January 11, 2018 | Volume: 42 | Issue: 4 | Pages: 506-511

10.1097/pas.0000000000001023 | PMID 29324471 Get It

Atypical teratoid/rhabdoid tumor (ATRT) is a highly malignant brain tumor predominantly encountered in infants. Mutations of the SMARCB1 gene are the characteristic genetic lesion. A small group of ATRT stands out clinically, because these tumors are located in the sellar region of adults. To investigate if sellar region ATRT in adults represents a molecular distinct entity, we characterized molecular alterations in 7 sellar region ATRTs in adults as compared with 150 pediatric ATRTs and 47 pituitary adenomas using SMARCB1 sequencing, multiplex ligation-dependent probe amplification and fluorescence in situ hybridization as well as DNA methylation profiling. The median age of the 6 female and 1 male patients was 56 years. On histopathologic examination, all tumors were malignant rhabdoid tumors showing loss of SMARCB1/INI1 protein expression. Two cases displayed compound heterozygous SMARCB1 point mutations, 3 cases showed heterozygous SMARCB1 deletions with point mutations of the other allele and 1 case a homozygous SMARCB1 deletion; in 1 case, underlying SMARCB1 alterations could not be identified. On unsupervised hierarchical cluster analysis of DNA methylation profiles, sellar region ATRTs did not form a distinct group, but clustered with ATRT-MYC, 1 of 3 recently described molecular subgroups of ATRT. On analysis of DNA methylation array intensity data, only 1 sellar region ATRT showed characteristic features of pediatric ATRT-MYC, that is, major copy number losses affecting the SMARCB1 region. In conclusion, these results suggest that sellar region ATRTs in adults form a clinically distinct entity with a different mutational spectrum, but epigenetic similarities with pediatric ATRTs of the ATRT-MYC subgroup.
Recurrent Monocular Vision Loss and an Ocular Mass
Sathiamoorthi, Saraniya , Leavitt, Jacqueline A., Chen, John J. , Chen, John J

Mayo Clinic

JAMA Ophthalmology | January 11, 2018 | Volume: 136 | Issue: 4 | Pages: 440

10.1001/jamaophthalmol.2017.4285 | PMID 29327035 Get It